ARS Pharmaceuticals Inc.

SPRY | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.43

+$0.08 (+1.84%)

Sep 22, 2026, 1:19 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-171.3M	8M	-54.37M	-34.68M	-20.24M	-1.07M
Depreciation & Amortization	1.37M	-7.18M	73K	319K	213K	6K
Stock-Based Compensation	22.1M	14.53M	9.24M	5.84M	2.83M	3.54M
Other Working Capital	306K	-4.12M	-4.55M	-2.47M	-356K	4.67M
Other Non-Cash Items	-3.03M	n/a	-6.88M	1.2M	-4K	121K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	1K
Change in Working Capital	-20M	-1.81M	-7.33M	-12.75M	-356K	6.46M
Operating Cash Flow	-170.87M	13.55M	-59.27M	-40.08M	-17.56M	9.07M
Capital Expenditures	-339K	-563K	-175K	-199K	-55K	-917K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-242.03M	-356.04M	-272.01M	n/a	n/a	n/a
Sales Maturities Of Investments	307M	258M	185M	n/a	n/a	n/a
Other Investing Acitivies	-7.86M	-7.5M	n/a	n/a	n/a	n/a
Investing Cash Flow	56.77M	-106.1M	-87.18M	-199K	-55K	-917K
Debt Repayment	96.26M	69.38M	n/a	-8.68M	-1.82M	5M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.66M	n/a	n/a	198.84M	n/a	-409.11M
Financial Cash Flow	104.6M	72.4M	6.9M	190.73M	53.16M	5.1M
Net Cash Flow	-9.5M	-20.15M	-139.55M	150.46M	35.54M	14.17M
Free Cash Flow	-171.21M	12.99M	-59.44M	-40.28M	-17.62M	8.15M
Adj. Free Cash Flow	-193.3M	-1.55M	-68.68M	-46.12M	-20.45M	4.61M
Maintenance CapEx	-339K	n/a	-175K	-199K	-55K	n/a
Growth CapEx	n/a	-563K	n/a	n/a	n/a	-917K
Owner Earnings	-171.21M	13.55M	-59.44M	-40.28M	-17.62M	9.07M